Lexaria Bioscience Corp. (LEXX)
NASDAQ·Healthcare·Biotechnology
$3.45
+0.73%
Mkt Cap $14.10M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
-56.5%
Consensus $1.50 vs current $3.45
NASDAQ·Healthcare·Biotechnology
$3.45
+0.73%
Mkt Cap $14.10M
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
-56.5%
Consensus $1.50 vs current $3.45